Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Health & Medicine
Over 500 speakers to join Global Health Forum 2026 in Riyadh
Global Health Forum 2026 will feature more than 500 international speakers across four specialized conference stages in Riyadh this October.
Vance’s anti-fraud task force to remove 750,000 allegedly fraudulent ACA enrollments
Vice President JD Vance said the move will save $2.2 billion by preventing "rampant" fraud.
Could xylitol be less heart-friendly than we thought?
A recent study has linked higher blood levels of the sugar substitute with greater risk of heart attack, stroke and death - but researchers say cause and effect remain unproven.
China’s cancer breakthrough on CAR-T cell therapy shows progress
In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai.
China’s cancer breakthrough on CAR-T cell therapy shows progress
In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai.
China’s cancer breakthrough on CAR-T cell therapy shows progress
In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai.